Carrie L. Wright, Ph.D. - Publications

Affiliations: 
Biomedical Sciences University of New Mexico, Albuquerque, NM, United States 
Area:
RNA stability, GAP-43, HUD, Schizophrenia

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Wright C, Shin JH, Rajpurohit A, Williams C, Jaffe A, Brandon N, Hyde T, Kleinman J, Cross A, Weinberger D. Characterization of miRNA Isoform Expression In Schizophrenia Using Postmortem Human Brain Tissue European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.06.034  0.384
2019 Wright C, Cairns M, Weinberger D. Novel Implications For RNA In Psychiatric Genetics European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2017.06.033  0.389
2018 Rosenberg AZ, Wright C, Fox-Talbot K, Rajpurohit A, Williams C, Porter C, Kovbasnjuk O, McCall MN, Shin JH, Halushka MK. xMD-miRNA-seq to generate near in vivo miRNA expression estimates in colon epithelial cells. Scientific Reports. 8: 9783. PMID 29955168 DOI: 10.1038/S41598-018-28198-Z  0.346
2017 Wright C, Shin JH, Rajpurohit A, Deep-Soboslay A, Collado-Torres L, Brandon NJ, Hyde TM, Kleinman JE, Jaffe AE, Cross AJ, Weinberger DR. Altered expression of histamine signaling genes in autism spectrum disorder. Translational Psychiatry. 7: e1126. PMID 28485729 DOI: 10.1038/Tp.2017.87  0.343
2017 Maphis NM, Jiang S, Binder J, Wright C, Gopalan B, Lamb BT, Bhaskar K. Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology. Frontiers in Molecular Neuroscience. 10: 69. PMID 28367114 DOI: 10.3389/Fnmol.2017.00069  0.301
2016 Wright C, Gupta CN, Chen J, Patel V, Calhoun VD, Ehrlich S, Wang L, Bustillo JR, Perrone-Bizzozero NI, Turner JA. Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia. Translational Psychiatry. 6: e724. PMID 26836412 DOI: 10.1038/Tp.2015.211  0.669
2015 Patel VS, Kelly S, Wright C, Gupta CN, Arias-Vasquez A, Perrone-Bizzozero N, Ehrlich S, Wang L, Bustillo JR, Morris D, Corvin A, Cannon DM, McDonald C, Donohoe G, Calhoun VD, et al. MIR137HG risk variant rs1625579 genotype is related to corpus callosum volume in schizophrenia. Neuroscience Letters. PMID 26123324 DOI: 10.1016/J.Neulet.2015.06.039  0.647
2015 Wright C, Calhoun VD, Ehrlich S, Wang L, Turner JA, Bizzozero NI. Meta gene set enrichment analyses link miR-137-regulated pathways with schizophrenia risk. Frontiers in Genetics. 6: 147. PMID 25941532 DOI: 10.3389/Fgene.2015.00147  0.659
2015 Gupta CN, Chen J, Liu J, Damaraju E, Wright C, Perrone-Bizzozero NI, Pearlson G, Luo L, Michael AM, Turner JA, Calhoun VD. Genetic markers of white matter integrity in schizophrenia revealed by parallel ICA. Frontiers in Human Neuroscience. 9: 100. PMID 25784871 DOI: 10.3389/Fnhum.2015.00100  0.613
2015 Hass J, Walton E, Wright C, Beyer A, Scholz M, Turner J, Liu J, Smolka MN, Roessner V, Sponheim SR, Gollub RL, Calhoun VD, Ehrlich S. Associations between DNA methylation and schizophrenia-related intermediate phenotypes - a gene set enrichment analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 59: 31-9. PMID 25598502 DOI: 10.1016/J.Pnpbp.2015.01.006  0.633
2013 Wright C, Turner JA, Calhoun VD, Perrone-Bizzozero N. Potential Impact of miR-137 and Its Targets in Schizophrenia. Frontiers in Genetics. 4: 58. PMID 23637704 DOI: 10.3389/Fgene.2013.00058  0.678
Show low-probability matches.